Viracta Therapeutics, Inc.
VIRX
$0.022
$0.005533.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.25% | 21.26% | 25.13% | -33.30% | 28.99% |
| Total Depreciation and Amortization | -14.06% | -19.33% | -9.84% | 115.79% | 184.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.49% | -19.87% | -5.60% | -24.03% | -83.16% |
| Change in Net Operating Assets | 227.54% | -142.44% | 62.23% | 258.63% | -77.88% |
| Cash from Operations | 32.67% | -22.99% | 30.78% | -26.88% | -47.20% |
| Capital Expenditure | -- | -- | -- | -- | 5,200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.80% | 180.71% | 293.09% | 4,666.50% | 117.38% |
| Cash from Investing | -10.31% | 194.05% | 293.09% | 4,666.50% | 117.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -78.43% | 400.00% | -84.66% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -78.92% | -41,337.50% | -98.98% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.57% | 150.42% | 98.63% | -104.05% | 97.53% |